MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 9, 2009, Pages 3507-3512

  Kocerh, Jannet ^a   Ali Faghihi, Mohammad ^a   Lopez Toledano, Miguel A ^a   Huang, Jia ^a,f   Ramsey, Amy J ^b   Caron, Marc G ^b   Sales, Nicole ^a   Willoughby, David ^c   Elmen, Joacim ^d   Hansen, Henrik F ^d   Orum, Henrik ^d   Kauppinen, Sakari ^d,e   Kenny, Paul J ^a   Wahlestedt, Claes ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Ocean Ridge Biosciences   (United States)

^d Santaris Pharma AS   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; Glutamatergic signaling; Regulatory RNA

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE 2 GAMMA; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CLOZAPINE; DIZOCILPINE; HALOPERIDOL; MESSENGER RNA; MICRORNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN FUNCTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; GENE CONTROL; GENETIC POLYMORPHISM; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL TRANSPORT; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL LINE, TUMOR; DIZOCILPINE MALEATE; GENE EXPRESSION REGULATION; GENE THERAPY; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NERVOUS SYSTEM DISEASES; PROTEIN SUBUNITS; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

MURINAE; MUS;

EID: 62549091540     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805854106     Document Type: Article

References (46)

1. Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 8:413-426.
2. Coyle JT (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry 3:241-253.
3. Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J (2001) Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57:1618-1628.
4. Dorval KM, et al. (2007) Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 6:444-452.
5. Javitt DC (2007) Glutamate and Schizophrenia: Phencyclidine, N-Methyl-D-Aspartate Receptors, and Dopamine-Glutamate Interactions. Int Rev Neurobiol 78:69-108.
6. Carlsson ML (1998) Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy. J Neural Transm 105:525-535.
7. Moy SS, et al. (2008) Development of a mouse test for repetitive, restricted behaviors: Relevance to autism. Behav Brain Res 188:178-194.
8. Lehohla M, Kellaway L, Russell VA (2004) NMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorder. Metab Brain Dis 19:35-42.
9. Adams J, et al. (2004) Glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol Psychiatry 9:494-499.
10. Beneyto M, Meador-Woodruff JH (2007) Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 9:2175-2186.
11. Cammarota M, et al. (2002) Participation of CaMKII in neuronal plasticity and memory formation. Cell Mol Neurobiol 22:259-267.
12. Schratt GM, et al. (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289.
13. Miska EA, et al. (2004) Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5:R68.
14. Sempere LF, et al. (2004) Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation. Genome Biol 5:R13.
15. Klein ME, Impey S, Goodman RH (2005) Role reversal: The regulation of neuronal gene expression by microRNAs. Curr Opin Neurobiol 15:507-513.
16. Abelson JF, et al. (2005) Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
17. Hansen T, et al. (2007) Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2:e873.
18. Burmistrova OA, et al. (2007) MicroRNA in schizophrenia: Genetic and expression analysis of miR-130b (22q11). Biochemistry 72:578-582.
19. Perkins DO, et al. (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:R27.
20. Nomura T, et al. (2008) MeCP2-dependent repression of an imprinted miR-184 released by depolarization. Hum Mol Genet 17(8):1192-1199.
21. Kosik KS (2006) The neuronal microRNA system. Nat Rev Neurosci 7:911-920.
22. Kosik KS, Krichevsky AM (2005) The elegance of the microRNAs: A neuronal perspective. Neuron 47:779-782.
23. Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15:563-568.
24. Heresco-Levy U, Javitt DC (1998) The role of N-methyl-D- aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol 8:141-152.
25. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
26. Cheng HY, et al. (2007) microRNA modulation of circadian-clock period and entrainment. Neuron 54:813-829.
27. Lukiw WJ (2007) Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 18:297-300.
28. Druhan JP, Rajabi H, Stewart J (1996) MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens. Synapse 24:135-146.
29. Zuo DY, et al. (2006) Effect of acute and chronic MK-801 administration on extracellular glutamate and ascorbic acid release in the prefrontal cortex of freely moving mice on line with open-field behavior. Life Sci 78:2172-2178.
30. Gisabella B, Cunningham MG, Bolshakov VY, Benes FM (2008) Amygdala-dependent regulation of electrical properties of hippocampal interneurons in a model of schizophrenia. Biol Psychiatry, in press.
31. Patil ST, et al. (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial. Nat Med 13:1102-1107.
32. Suen PC, et al. (1998) NMDA receptor subunits in the postsynaptic density of rat brain: Expression and phosphorylation by endogenous protein kinases. Brain Res Mol Brain Res 59:215-228.
33. Miller S, et al. (2002) Disruption of dendritic translation of CaMKIIalpha impairs stabilization of synaptic plasticity and memory consolidation. Neuron 36:507-519.
34. Kye MJ, et al. (2007) Somatodendritic microRNAs identified by laser capture and multiplex RT-PCR. RNA 13:1224-1234.
35. Wahlestedt C, et al. (2000) Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci USA 97:5633-5638.
36. Thakker DR, et al. (2004) Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference. Proc Natl Acad Sci USA 101:17270-17275.
37. Thakker DR, et al. (2005) siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry 10:782-789.
38. Elmen J, et al. (2007) Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 36:1153-1162.
39. Elmen J, et al. (2008) LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899
40. Bubenikova-Valesova V, Horacek J, Vrajova M, Hoschl C (2008) Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 32:1014-1023.
41. Kaindl AM, et al. (2008) Brief alteration of NMDA or GABAA receptor mediated neurotransmission has long-term effects on the developing cerebral cortex. Mol Cell Proteomics 7:2293-2310.
42. Di Pietro NC, Seamans JK (2007) Dopamine and serotonin interactions in the prefrontal cortex: Insights on antipsychotic drugs and their mechanism of action. Pharmacopsychiatry 40(Suppl 1):S27-S33.
43. Corbett R, et al. (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74.
44. Ninan I, Jardemark KE, Liang X, Wang RY (2003) Calcium/calmodulin- dependent kinase II is involved in the facilitating effect of clozapine on NMDA- and electrically evoked responses in the medial prefrontal cortical pyramidal cells. Synapse 47:285-294.
45. White IM, et al. (1995) Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine. J Neural Transm Gen Sect 102:99-112.
46. Jones-Villeneuve EM, McBurney MW, Rogers KA, Kalnins VI (1982) Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J Cell Biol 94:253-262.